Baseline PSA testing for men in their 40s: Currently available evidence strongly supports baseline PSA measurements in this age group

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

The benefit-to-risk trade-offs associated with PSA screening are highly sensitive to patient preference, underscoring the importance of ensuring that men have the opportunity to decide for themselves whether they wish to have their individual risk for suffering and death from prostate cancer assessed through PSA screening.

Original languageEnglish (US)
JournalONCOLOGY (United States)
Volume28
Issue number2
StatePublished - Feb 15 2014

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Baseline PSA testing for men in their 40s: Currently available evidence strongly supports baseline PSA measurements in this age group'. Together they form a unique fingerprint.

Cite this